Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden
· Delayed Price · Currency is SEK 0.275
-0.025 (-8.33%)
Mar 21, 2025, 5:29 PM CET
STO:LPGO Revenue
Lipigon Pharmaceuticals AB had revenue of 8.97M SEK in the twelve months ending September 30, 2024, down -45.33% year-over-year. In the year 2023, Lipigon Pharmaceuticals AB had annual revenue of 16.41M.
Revenue (ttm)
8.97M
Revenue Growth
-45.33%
P/S Ratio
3.30
Revenue / Employee
1.50M
Employees
6
Market Cap
40.79M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.30B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Elekta AB | 17.88B |
| Bonesupport Holding AB | 898.73M |